Physician profile
Mark H Bernhard
NPI 1912924515
$1,491.01
in general payments reported to CMS, 2019-2025
17 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.20 · 2020: $190 · 2021: $13.41 · 2022: $170 · 2023: $329 · 2024: $539 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $287.75 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $226.72 | 2022-2025 | |
| Inspire Medical Systems, INC. | $200.51 | 2024-2025 | Inspire |
| Glaxosmithkline, LLC. | $149.95 | 2023-2025 | Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $130.69 | 2024-2025 | Airsupra, Breztri |
| Abbott Laboratories | $124.29 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.82 | 2022-2025 | Jardiance |
| Lilly USA, LLC | $57.15 | 2022-2024 | Jardiance |
| Amgen INC. | $43.55 | 2025 | Otezla, Repatha, Krystexxa |
| Medtronic, INC. | $40.41 | 2022-2025 | Inceptiv |
| Exact Sciences Corporation | $33.62 | 2024 | Cologuard Collection Kit |
| Ultragenyx Pharmaceutical INC. | $20.34 | 2022 | |
| Abbvie INC. | $19.23 | 2025 | |
| Astellas Pharma US INC | $19.06 | 2023 | Veozah |
| Pfizer INC. | $18.39 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $16.95 | 2020 | |
| Amarin Pharma, INC. | $15.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bernhard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.